ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $228,481 | -54.5% | 6,409 | -41.1% | 0.00% | -100.0% |
| Q2 2023 | $502,356 | +91.2% | 10,890 | +66.2% | 0.00% | – |
| Q1 2023 | $262,775 | -24.5% | 6,553 | -21.9% | 0.00% | -100.0% |
| Q3 2022 | $348,000 | -82.2% | 8,390 | -74.4% | 0.00% | -66.7% |
| Q2 2022 | $1,959,000 | -55.7% | 32,835 | -46.1% | 0.00% | -50.0% |
| Q1 2022 | $4,425,000 | +837.5% | 60,935 | +985.2% | 0.01% | +500.0% |
| Q4 2021 | $472,000 | -74.7% | 5,615 | -72.9% | 0.00% | -66.7% |
| Q3 2021 | $1,869,000 | -78.7% | 20,715 | -77.5% | 0.00% | -75.0% |
| Q2 2021 | $8,775,000 | -43.5% | 92,029 | -32.6% | 0.01% | -47.8% |
| Q1 2021 | $15,536,000 | -23.4% | 136,448 | -6.9% | 0.02% | -32.4% |
| Q4 2020 | $20,294,000 | +77.8% | 146,603 | +5.6% | 0.03% | +61.9% |
| Q3 2020 | $11,412,000 | +605.3% | 138,837 | +571.4% | 0.02% | +600.0% |
| Q2 2020 | $1,618,000 | -48.9% | 20,679 | -71.0% | 0.00% | -57.1% |
| Q1 2020 | $3,165,000 | +233.2% | 71,220 | +220.1% | 0.01% | +600.0% |
| Q4 2019 | $950,000 | +193.2% | 22,250 | +335.4% | 0.00% | 0.0% |
| Q2 2019 | $324,000 | -6.1% | 5,110 | +2.6% | 0.00% | 0.0% |
| Q1 2019 | $345,000 | +3.3% | 4,980 | +13.7% | 0.00% | – |
| Q3 2018 | $334,000 | -0.9% | 4,380 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $337,000 | +59.7% | 4,380 | +6.1% | 0.00% | – |
| Q1 2018 | $211,000 | -85.0% | 4,130 | -86.4% | 0.00% | -100.0% |
| Q4 2017 | $1,407,000 | +48.9% | 30,334 | +71.0% | 0.00% | +100.0% |
| Q3 2017 | $945,000 | +125.0% | 17,740 | +162.0% | 0.00% | 0.0% |
| Q2 2017 | $420,000 | +69.4% | 6,770 | +85.0% | 0.00% | – |
| Q1 2017 | $248,000 | +2.1% | 3,660 | +5.8% | 0.00% | – |
| Q4 2016 | $243,000 | -0.8% | 3,460 | +0.3% | 0.00% | – |
| Q3 2016 | $245,000 | -18.1% | 3,450 | -27.0% | 0.00% | -100.0% |
| Q1 2016 | $299,000 | -15.3% | 4,724 | +50.0% | 0.00% | 0.0% |
| Q4 2015 | $353,000 | +26.5% | 3,150 | +8.6% | 0.00% | 0.0% |
| Q3 2015 | $279,000 | +7.3% | 2,900 | +14.2% | 0.00% | – |
| Q2 2015 | $260,000 | – | 2,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |